Dimerization of VEGF receptors and implications for signal transduction: A computational study

Biophysical Chemistry

Volumn 128, Issue 2-3, 2007, Pages 125-139

  Mac Gabhann, Feilim ^a   Popel, Aleksander S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Growth factor; Heterodimer; Homodimer; Mathematical model; Receptor tyrosine kinase

Indexed keywords

HETERODIMER; HOMODIMER; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ARTICLE; BINDING SITE; CELL SURFACE; DIMERIZATION; LIGAND BINDING; MATHEMATICAL MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

COMPUTER SIMULATION; MODELS, MOLECULAR; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 34249694937     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2007.03.010     Document Type: Article

References (61)

1. Folkman J. Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action. Exp. Cell Res. 312 (2006) 594-607
2. Maruotti N., Cantatore F.P., Crivellato E., Vacca A., and Ribatti D. Angiogenesis in rheumatoid arthritis. Histol. Histopathol. 21 (2006) 557-566
3. Wilkinson-Berka J.L. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr. Pharm. Des. 10 (2004) 3331-3348
4. Olsson A.K., Dimberg A., Kreuger J., and Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat. Rev., Mol. Cell Biol. 7 (2006) 359-371
5. Shibuya M., and Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 312 (2006) 549-560
6. Potgens A.J., Lubsen N.H., van Altena M.C., Vermeulen R., Bakker A., Schoenmakers J.G., Ruiter D.J., and de Waal R.M. Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J. Biol. Chem. 269 (1994) 32879-32885
7. Walsh T.P., and Grant G.H. Computer modelling of the receptor-binding domains of VEGF and PIGF. Protein Eng. 10 (1997) 389-398
8. Wiesmann C., Fuh G., Christinger H.W., Eigenbrot C., Wells J.A., and de Vos A.M. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91 (1997) 695-704
9. Fuh G., Li B., Crowley C., Cunningham B., and Wells J.A. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J. Biol. Chem. 273 (1998) 11197-11204
10. Keyt B.A., Nguyen H.V., Berleau L.T., Duarte C.M., Park J., Chen H., and Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271 (1996) 5638-5646
11. Tao Q., Backer M.V., Backer J.M., and Terman B.I. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling. J. Biol. Chem. 276 (2001) 21916-21923
12. Cunningham S.A., Tran T.M., Arrate M.P., and Brock T.A. Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. A real time kinetic study. J. Biol. Chem. 274 (1999) 18421-18427
13. Shinkai A., Ito M., Anazawa H., Yamaguchi S., Shitara K., and Shibuya M. Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor. J. Biol. Chem. 273 (1998) 31283-31288
14. Huang X., Gottstein C., Brekken R.A., and Thorpe P.E. Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance. Biochem. Biophys. Res. Commun. 252 (1998) 643-648
15. Boesen T.P., Soni B., Schwartz T.W., and Halkier T. Single-chain vascular endothelial growth factor variant with antagonist activity. J. Biol. Chem. 277 (2002) 40335-40341
16. von Tiedemann B., and Bilitewski U. Characterization of the vascular endothelial growth factor-receptor interaction and determination of the recombinant protein by an optical receptor sensor. Biosens. Bioelectron. 17 (2002) 983-991
17. Neagoe P.E., Lemieux C., and Sirois M.G. Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer. J. Biol. Chem. 280 (2005) 9904-9912
18. Mac Gabhann F., and Popel A.S. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H153-H164
19. Mac Gabhann F., and Popel A.S. Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2851-H2860
20. Mac Gabhann F., Ji J.W., and Popel A.S. Computational Model of VEGF Spatial Distribution in Muscle and Pro-Angiogenic Cell Therapy. PLoS Comp. Biol. 2 (2006) e127
21. Mac Gabhann F., Yang M.T., and Popel A.S. Monte Carlo simulations of VEGF binding to cell surface receptors in vitro. Biochim. Biophys. Acta 1746 (2005) 95-107
22. Haugh J.M. Mathematical model of human growth hormone (hGH)-stimulated cell proliferation explains the efficacy of hGH variants as receptor agonists or antagonists. Biotechnol. Prog. 20 (2004) 1337-1344
23. Gopalakrishnan M., Forsten-Williams K., and Tauber U.C. Ligand-induced coupling versus receptor pre-association: cellular automaton simulations of FGF-2 binding. J. Theor. Biol. 227 (2004) 239-251
24. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110 (2002) 669-672
25. Klein P., Mattoon D., Lemmon M.A., and Schlessinger J. A structure-based model for ligand binding and dimerization of EGF receptors. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 929-934
26. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306 (2004) 1506-1507
27. Hendriks B.S., Opresko L.K., Wiley H.S., and Lauffenburger D. Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels. J. Biol. Chem. 278 (2003) 23343-23351
28. Mayawala K., Vlachos D.G., and Edwards J.S. Computational modeling reveals molecular details of epidermal growth factor binding. BMC Cell Biol. 6 (2005) 41
29. Mayawala K., Vlachos D.G., and Edwards J.S. Spatial modeling of dimerization reaction dynamics in the plasma membrane: Monte Carlo vs. continuum differential equations. Biophys. Chemist. 121 (2006) 194-208
30. Blinov M.L., Faeder J.R., Goldstein B., and Hlavacek W.S. A network model of early events in epidermal growth factor receptor signaling that accounts for combinatorial complexity. Biosystems 83 (2006) 136-151
31. Forsten-Williams K., Chua C.C., and Nugent M.A. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J. Theor. Biol. 233 (2005) 483-499
32. Chua C.C., Rahimi N., Forsten-Williams K., and Nugent M.A. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ. Res. 94 (2004) 316-323
33. Filion R.J., and Popel A.S. A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors. Ann. Biomed. Eng. 32 (2004) 645-663
34. Fredriksson L., Li H., and Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 15 (2004) 197-204
35. Roy H., Bhardwaj S., and Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett. 580 (2006) 2879-2887
36. Park C.S., Schneider I.C., and Haugh J.M. Kinetic analysis of platelet-derived growth factor receptor/phosphoinositide 3-kinase/Akt signaling in fibroblasts. J. Biol. Chem. 278 (2003) 37064-37072
37. Bikfalvi A., Sauzeau C., Moukadiri H., Maclouf J., Busso N., Bryckaert M., Plouet J., and Tobelem G. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. J. Cell. Physiol. 149 (1991) 50-59
38. Brogi E., Schatteman G., Wu T., Kim E.A., Varticovski L., Keyt B., and Isner J.M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97 (1996) 469-476
39. Li S., Peck-Radosavljevic M., Koller E., Koller F., Kaserer K., Kreil A., Kapiotis S., Hamwi A., Weich H.A., Valent P., Angelberger P., Dudczak R., and Virgolini I. Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int. J. Cancer 91 (2001) 789-796
40. Myoken Y., Kayada Y., Okamoto T., Kan M., Sato G.H., and Sato J.D. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 5819-5823
41. Thieme H., Aiello L.P., Takagi H., Ferrara N., and King G.L. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44 (1995) 98-103
42. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., and Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269 (1994) 26988-26995
43. Wang D., Lehman R.E., Donner D.B., Matli M.R., Warren R.S., and Welton M.L. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. Am. J. Physiol. Gasterointest. Liver Physiol. 282 (2002) G1088-G1096
44. Whitaker G.B., Limberg B.J., and Rosenbaum J.S. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J. Biol. Chem. 276 (2001) 25520-25531
45. Forsten K.E., and Lauffenburger D.A. The role of low-affinity interleukin-2 receptors in autocrine ligand binding: alternative mechanisms for enhanced binding effect. Mol. Immunol. 31 (1994) 739-751
46. Dembo M., Kagey-Sobotka A., Lichtenstein L.M., and Goldstein B. Kinetic analysis of histamine release due to covalently linked IgE dimers. Mol. Immunol. 19 (1982) 421-434
47. Shea L.D., Omann G.M., and Linderman J.J. Calculation of diffusion-limited kinetics for the reactions in collision coupling and receptor cross-linking. Biophys. J. 73 (1997) 2949-2959
48. Dougher M., and Terman B.I. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization. Oncogene 18 (1999) 1619-1627
49. Berk D.A., Yuan F., Leunig M., and Jain R.K. Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media. Biophys. J. 65 (1993) 2428-2436
50. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., and Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 (1996) 3336-3343
51. Keyt B.A., Berleau L.T., Nguyen H.V., Chen H., Heinsohn H., Vandlen R., and Ferrara N. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271 (1996) 7788-7795
52. Shen H., Clauss M., Ryan J., Schmidt A.M., Tijburg P., Borden L., Connolly D., Stern D., and Kao J. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81 (1993) 2767-2773
53. Siemeister G., Schirner M., Reusch P., Barleon B., Marme D., and Martiny-Baron G. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4625-4629
54. Kendall R.L., Wang G., DiSalvo J., and Thomas K.A. Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem. Biophys. Res. Commun. 201 (1994) 326-330
55. Dixelius J., Makinen T., Wirzenius M., Karkkainen M.J., Wernstedt C., Alitalo K., and Claesson-Welsh L. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J. Biol. Chem. 278 (2003) 40973-40979
56. Huang K., Andersson C., Roomans G.M., Ito N., and Claesson-Welsh L. Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. Int. J. Biochem. Cell. Biol. 33 (2001) 315-324
57. Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., Kroll J., Plaisance S., De Mol M., Bono F., Kliche S., Fellbrich G., Ballmer-Hofer K., Maglione D., Mayr-Beyrle U., Dewerchin M., Dombrowski S., Stanimirovic D., Van Hummelen P., Dehio C., Hicklin D.J., Persico G., Herbert J.M., Shibuya M., Collen D., Conway E.M., and Carmeliet P. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9 (2003) 936-943
58. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., DiPalma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.M., Collen D., and Persico M.G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7 (2001) 575-583
59. Li B., Fuh G., Meng G., Xin X., Gerritsen M.E., Cunningham B., and de Vos A.M. Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization. J. Biol. Chem. 275 (2000) 29823-29828
60. Muller Y.A., Christinger H.W., Keyt B.A., and de Vos A.M. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding. Structure 5 (1997) 1325-1338
61. Pan B., and Fairbrother W.J. 1H, 13C, and 15N resonance assignment of the vascular endothelial growth factor receptor-binding domain in complex with a receptor-blocking peptide. J. Biomol. NMR 22 (2002) 189-190